Inclisiran in primary prevention: reality or fiction?

Eur Heart J. 2022 Dec 21;43(48):5058-5060. doi: 10.1093/eurheartj/ehac653.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Anticholesteremic Agents*
  • Cholesterol, LDL
  • Humans
  • RNA, Small Interfering

Substances

  • ALN-PCS
  • Anticholesteremic Agents
  • Cholesterol, LDL
  • RNA, Small Interfering